| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/03/2008 | WO2008002946A2 Method of modulating neurite outgrowth by the use of a galanin-3 receptor antagonist |
| 01/03/2008 | WO2008002820A2 Substituted benzyl amine compounds |
| 01/03/2008 | WO2008002818A1 Substituted aminomethyl benzamide compounds |
| 01/03/2008 | WO2008002817A1 Butyl and butynyl benzyl amine compounds |
| 01/03/2008 | WO2008002816A1 Substituted benzamide modulators of the histamine h3 receptor |
| 01/03/2008 | WO2008002629A1 Process for the preparation of zopiclone |
| 01/03/2008 | WO2008002602A1 Use of n-desmethylclozapine to treat psychosis |
| 01/03/2008 | WO2008002583A1 Glycine transporter-1 inhibitors |
| 01/03/2008 | WO2008002539A1 Combinations comprising 5ht6 modulators and cholinesterase inhibitors |
| 01/03/2008 | WO2008002250A1 Improved stem cells for transplantation and methods for production thereof |
| 01/03/2008 | WO2008002245A2 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 01/03/2008 | WO2008002244A2 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 01/03/2008 | WO2008001959A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 01/03/2008 | WO2008001930A1 Pyridylisoxazole derivative |
| 01/03/2008 | WO2008001912A1 Substituted benzyl ester derivative and use thereof |
| 01/03/2008 | WO2008001859A1 OPIOID δ RECEPTOR AGONIST |
| 01/03/2008 | WO2008001495A1 Agent against psychosocial stresses |
| 01/03/2008 | WO2008001369A1 Use of cb2 receptor agonists for promoting neurogenesis |
| 01/03/2008 | WO2008001182A1 Tricyclic heteroaryl compounds as pde10 inhibitors |
| 01/03/2008 | WO2008001134A1 1,2,3,8,9,9a-hexahydro-7h-benzo(de)-1,7-naphthyridin-7-one derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 01/03/2008 | WO2008001113A2 Use of wnt5a for inhibiting scarring |
| 01/03/2008 | WO2008001053A1 Treatment and/or prevention of pain using polyether polyols |
| 01/03/2008 | WO2008000968A1 Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same |
| 01/03/2008 | WO2008000967A1 Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same |
| 01/03/2008 | WO2008000951A2 Urea derivatives of tropane, their preparation and their therapeutic application |
| 01/03/2008 | WO2008000745A2 Adenosine derivatives for the treatment of pain |
| 01/03/2008 | WO2008000744A2 2-0'-methyladen0sine derivatives and their use as agonists or antagonists of an adenosine receptor |
| 01/03/2008 | WO2008000743A2 Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists |
| 01/03/2008 | WO2008000643A1 Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same |
| 01/03/2008 | WO2008000513A2 Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 01/03/2008 | WO2008000469A2 Nicotinic agonists selective for the alpha7 receptor subtype, the process for the preparation thereof and pharmaceutical compositions therefrom |
| 01/03/2008 | WO2008000447A1 New formulation for increasing bioavailability of neurturin |
| 01/03/2008 | WO2008000430A2 Alphanizomenon flos aquae preparation, extracts and purified components thereof for the treatment of neurological, neurodegenerative and mood disorders |
| 01/03/2008 | WO2008000166A1 Granule and preparation method thereof |
| 01/03/2008 | WO2008000142A1 Dopamine transporter agonist and its use |
| 01/03/2008 | WO2008000070A1 Glycyrrhetinic acid derivatives |
| 01/03/2008 | WO2008000042A1 Methods for the preparation of biologically active compounds in nanoparticulate form |
| 01/03/2008 | WO2007130822A3 Mglur5 modulators iii |
| 01/03/2008 | WO2007120729A3 Pyridyl amide t-type calcium channel antagonists |
| 01/03/2008 | WO2007089626A3 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof |
| 01/03/2008 | WO2007060491A3 Pharmaceutical compositions comprising a sodium channel blocker in combination with a mao-b- inhibitor |
| 01/03/2008 | WO2007019111A3 Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/03/2008 | WO2004022039A3 Use of guanosine or inosine as anti-apoptotic agents in the treatment of i. a. neurodegenerative diseases or injuries at the nervous system |
| 01/03/2008 | US20080004353 Administration of 2-propanone-1,3,5,5-trimethyl-2-cyclohexen-1-ylidine or its isomers, salts or solvates for therapy of epilepsy or seizures |
| 01/03/2008 | US20080004352 serotonin (5-HT2C) receptor antagonist; antidepressant, anxiolytic agent; seasonal affective disorders, sleep disorders, cardiovascular pathologies, pathologies of the digestive system, insomnia and fatigue resulting from jetlag, appetite disorders and obesity |
| 01/03/2008 | US20080004351 Using metal hydrogenation catalyst in trickel bed reractor |
| 01/03/2008 | US20080004349 Naphthalene compounds |
| 01/03/2008 | US20080004347 serotonin (5-HT2C) receptor antagonist; antidepressant, anxiolytic agent; seasonal affective disorders, sleep disorders, cardiovascular pathologies, pathologies of the digestive system, insomnia and fatigue resulting from jetlag, appetite disorders and obesity |
| 01/03/2008 | US20080004344 Novel Salts of Fumaric Acid Monoalkylesters and Their Pharmaceutical Use |
| 01/03/2008 | US20080004338 Use of enantiomeric pure escitalopram |
| 01/03/2008 | US20080004337 Therapeutic Agent for Substance Dependence |
| 01/03/2008 | US20080004334 Thiolactones |
| 01/03/2008 | US20080004332 Methods for alzheimer's disease treatment and cognitive enhancement |
| 01/03/2008 | US20080004330 Aminomethyl-Azacycle Derivatives as Inhibitors of Monoamine Uptake |
| 01/03/2008 | US20080004318 Substituted Bicyclic and Tricyclic Thrombin Receptor Antagonists |
| 01/03/2008 | US20080004316 Novel aminopyridine derivatives as mGluR5 antagonists |
| 01/03/2008 | US20080004314 Phenylpiperidines and Phenylpyrrolidines |
| 01/03/2008 | US20080004307 Azaindoles Having Serotonin Receptor Affinity |
| 01/03/2008 | US20080004306 Compositions and methods for modulating gated ion channels |
| 01/03/2008 | US20080004305 Intranasal Opioid Compositions |
| 01/03/2008 | US20080004304 Aryl Spirolactam Cgrp Receptor Antagonists |
| 01/03/2008 | US20080004293 Adenosine receptor antagonists and methods of making and using the same |
| 01/03/2008 | US20080004284 Method for treating fibromyalgia syndrome and related conditions |
| 01/03/2008 | US20080004270 3,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) Inhibitors |
| 01/03/2008 | US20080004269 Pyrazolylmethy Heteroaryl Derivatives |
| 01/03/2008 | US20080004264 Rapamycin analogues and the uses thereof in the treatment of neurological disorders |
| 01/03/2008 | US20080004258 such as [2-(3,4-Dichloro-phenoxy)-5-(4-morpholin-4-yl-but-1-ynyl)-benzyl]-methyl-amine, used as H3 receptor and/or serotonin transporter modulators useful in the treatment of cognitive, sleep and psychological disorders |
| 01/03/2008 | US20080004257 Kinase inhibitors |
| 01/03/2008 | US20080004255 Methods and compositions for altering cell function |
| 01/03/2008 | US20080004252 3-(3,4-Dichloro-phenoxy)-8-(1H-tetrazol-5-ylmethyl)-8-aza-bicyclo[3.2.1]octane; Central nervous system disorders |
| 01/03/2008 | US20080004251 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor |
| 01/03/2008 | US20080004249 Chemical Compounds |
| 01/03/2008 | US20080004244 Phosphono-carboxylate compounds for treating amyloidosis |
| 01/03/2008 | US20080004219 Reducing a cholinergic influenced secretion; treating smooth muscle disorders such as spasms |
| 01/03/2008 | US20080004211 Inhibitors of Amyloid Fibril Formation and Uses Thereof |
| 01/03/2008 | US20080003675 Methods and compositions for identifying morphogen analogs |
| 01/03/2008 | US20080003318 Reducing a cholinergic influenced secretion; treating smooth muscle disorders such as spasms |
| 01/03/2008 | US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/03/2008 | US20080003285 Immediate Release Pharmaceutical Tablets With Height Greater Than Width |
| 01/03/2008 | US20080003283 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 01/03/2008 | US20080003242 Botulinum toxin treatment for kinesia |
| 01/03/2008 | US20080003211 Production and Purification of Recombinant Arylsulftase |
| 01/03/2008 | US20080003209 Method for treatment of neurodegenerative diseases and the effects of aging |
| 01/03/2008 | US20080003208 Creatine-ligand compounds and methods of use thereof |
| 01/03/2008 | US20080003206 ABCB5 positive mesenchymal stem cells as immunomodulators |
| 01/03/2008 | US20080003181 Treatment of depressive disorders |
| 01/03/2008 | DE102006030366A1 Pharmaceutical composition useful for treating Parkinson's disease comprises a substance that specifically interacts with a homer1 gene |
| 01/03/2008 | CA2657973A1 Therapeutic compounds |
| 01/03/2008 | CA2656965A1 Medicaments |
| 01/03/2008 | CA2656159A1 Pyridylisoxazole derivatives |
| 01/03/2008 | CA2656154A1 Aphanizomenon flos aquae preparation, extracts and purified components thereof for the treatment of neurological, neurodegenerative and mood disorders |
| 01/03/2008 | CA2656089A1 Substituted benzyl amine compounds |
| 01/03/2008 | CA2656083A1 Substituted aminomethyl benzamide compounds |
| 01/03/2008 | CA2656075A1 Butyl and butynyl benzyl amine compounds |
| 01/03/2008 | CA2656072A1 Substituted benzamide modulators of the histamine h3 receptor |
| 01/03/2008 | CA2655987A1 Adenosine a2a receptor antagonists |
| 01/03/2008 | CA2655913A1 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |
| 01/03/2008 | CA2655829A1 Method of modulating neurite outgrowth by the use of a galanin-3 receptor antagonist |
| 01/03/2008 | CA2655828A1 Compositions and methods of treating cns disorders |
| 01/03/2008 | CA2655444A1 New compounds 385 |